1. |
From the Editor |
|
Inpharma Weekly,
Volume &NA;,
Issue 954,
1994,
Page 2-2
&NA;,
Preview
|
PDF (637KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
2. |
Beating influenza - mucosal vaccine makes sense |
|
Inpharma Weekly,
Volume &NA;,
Issue 954,
1994,
Page 3-3
Gill Higgins,
Preview
|
PDF (655KB)
|
|
摘要:
If an infection acts predominantly at mucosal surfaces, surely mucosal immunity is of vital importance? This is the argument that lies behind the development of a new vaccine for influenza. The vaccine is proving highly effective in animal studies and is conveniently formulated as an oral preparation. A quality control programme has now been set up to refine the vaccine for clinical trials, which are expected to begin within the next 12 months.
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
3. |
Views in the news |
|
Inpharma Weekly,
Volume &NA;,
Issue 954,
1994,
Page 4-4
&NA;,
Preview
|
PDF (698KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
4. |
News in brief… |
|
Inpharma Weekly,
Volume &NA;,
Issue 954,
1994,
Page 5-5
&NA;,
Preview
|
PDF (708KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
5. |
News in brief… |
|
Inpharma Weekly,
Volume &NA;,
Issue 954,
1994,
Page 6-6
&NA;,
Preview
|
PDF (663KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
6. |
News in brief… |
|
Inpharma Weekly,
Volume &NA;,
Issue 954,
1994,
Page 7-7
&NA;,
Preview
|
PDF (669KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
7. |
Stroke patients helped by early siagoside treatment |
|
Inpharma Weekly,
Volume &NA;,
Issue 954,
1994,
Page 8-8
&NA;,
Preview
|
PDF (655KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
8. |
Neuraminidase - a new point of attack in infectious disease |
|
Inpharma Weekly,
Volume &NA;,
Issue 954,
1994,
Page 9-9
Ian Mundell,
Preview
|
PDF (717KB)
|
|
摘要:
The enzyme neuraminidase [sialidase] is attracting attention as a target for infectious disease therapies. Structural determination of the different types of neuraminidase have proved particularly important, enabling rational drug design for various conditions. Glaxo is one of the companies at the forefront of this research, having initiated clinical trials of a neuraminidase inhibitor that could prove effective as a treatment for influenza.
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
9. |
Fusion toxin DAB486IL-2 promising |
|
Inpharma Weekly,
Volume &NA;,
Issue 954,
1994,
Page 10-10
&NA;,
Preview
|
PDF (673KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|
10. |
News in brief… |
|
Inpharma Weekly,
Volume &NA;,
Issue 954,
1994,
Page 11-11
&NA;,
Preview
|
PDF (679KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1994
数据来源: ADIS
|